Category: MassDevice.com Earnings RoundupSyndicate content

Medtronic's Q4 sales surge 60% on Covidien buy, outlook narrowed

May 19, 2015 by Brad Perriello

Medtronic's fiscal 4th-quarter sales surge nearly 60% thanks to its buyout earlier this year of Covidien, prompting the medical device company to tighten its earning forecast.

Medtronic's Q4 sales surge 60% on Covidien buy, outlook raised

Trial delays, Q1 profit slide pushes Neovasc shares down

May 15, 2015 by Fink Densford

Delays in Neovasc’s early feasibility trial for its Tiara transcatheter mitral valve implant and declining 1st-quarter profits push its stock price down.

Trial delays, Q1 profit slide hit Neovasc shares

Delays in Neovasc's (NSDQ:NVCN) early feasibility trial for its Tiara transcatheter mitral valve implant and declining 1st-quarter profits combined to push its stock price down this week.

Elekta sacks CEO Savander on 2014 sales plunge, shares plummet

May 13, 2015 by Brad Perriello

Elekta shares take a nosedive after the company badly misses expectations with its fiscal 2014 results, prompting the Swedish medtech giant to sack CEO Niklas Savander.

Elekta sacks CEO Savander on 2014 sales plunge, shares plummet

Robot-assisted surgery: Hansen Medical pares losses

May 11, 2015 by Mark Hollmer

Hansen Medical cuts its 1st-quarter losses and tops Wall Street's earnings estimates.

Robot-assisted surgery: Hansen Medical pares losses

A tale of 2 LVADs: Thoratec gains, HeartWare slides on Q1 results

May 11, 2015 by Brad Perriello

Shares of Thoratec rise after the heart pump maker beats Wall Street's forecast with its 1st-quarter results, but arch-rival HeartWare slides after just meeting The Street's bottom line.

A tale of 2 LVADs: Thoratec gains, HeartWare slideson Q1 results

FDA approves Nevro's Senza pain device ahead of schedule

May 11, 2015 by Brad Perriello

The FDA approves Nevro's Senza implantable pain device ahead of schedule and allows it claim superiority to other spinal cord stimulation devices; 1st-quarter sales and earnings top expectations.

FDA approves Nevro's Senza pain device ahead of schedule

Siemens misses profit expectations, cuts more jobs

May 7, 2015 by MassDevice

Siemens misses the mark with its fiscal 2nd-quarter results and says it will slash another 4,500 jobs from its global workforce.

Siemens misses profit expectations, cuts more jobs